Abstract
Uveal melanoma arises from melanocytes of the uveal tract (iris, ciliary body, and choroid) and represents the most common intraocular malignancy in adults. The mean age-adjusted incidence of uveal melanoma in the USA is approximately 4.3 new cases per million people, with no clear variation by latitude. Males have a higher incidence than females (4.9 vs. 3.7 per million). Uveal melanoma is diagnosed mostly at older ages, with a progressively rising, age-specific, incidence rate that peaks near the age of 70 years. Diagnosis often occurs late in the course of disease, and prognosis is generally poor.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Reading
Aronow M, Sun Y, Saunthararajah Y, Biscotti C, Tubbs R, Triozzi P, Singh AD. Monosomy 3 by FISH in uveal melanoma: variability in techniques and results. Surv Ophthalmol. 2012;57(5):463–73.
Cohen VML, Dinakaran S, Parsons MA, Rennie IG. Transvitreal fine needle aspiration biopsy: the influence of intraocular lesion size on diagnostic biopsy result. Eye. 2001;15:143–7.
Eide N, Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review. Acta Ophthalmol. 2009;83:588–601.
Ewens KG, Kanetsky PA, Richards-Yutz J, Al-Dahmash S, DeLuca MC, Bianciotto CG, Shields CL, Ganguly A. Genomic profile of 320 uveal melanoma cases: Chromosome 8p-loss and metastatic outcome. Invest Opthalmol Vis Sci. 2013;54(8):5721–9.
Field MG, Harbour JW. GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy? Cancer Cell. 2014a;25(6):714–5.
Field MG, Harbour JW. Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol. 2014b;25(3):234–9.
Hamadeh F, Medina CA, Singh AD, Reynolds JP, Biscotti CV. Posterior segment uveal melanoma: an analysis of potential prognostic cellular features. 2016 Diag Cytopathol (in press)
Homig-Holzel C, Savola S. Multiplex Ligation-Dependent Probe Amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol. 2012;21(4):189–206.
Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. Concurrent loss of chromosome arm 1p and chromosome 3 predict a decreased disease-free survival in uveal melanoma patients. Invest Opthalmol Vis Sci. 2005;46:2253–7.
McCannel TA. Fine-needle aspiration biopsy in the management of choroidal melanoma. Curr Opin Ophthalmol. 2013;24:262–6.
McCannel TA, Chang MY, Burgess BL. Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma. Ophthalmology. 2012;119:606–10.
Midena E, Bonald L, Parrozzani R, Tebaldi E, Boccassini B, Vujosevic S. In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy. Eur J Opthalmol. 2006;16:422–5.
Mudhar HS, Parsons MA, Sisley K, Rundle P, Singh A, Rennie IG. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma. Histopathology. 2004;45:1–12.
Naus NC, Verhoeven ACA, van Drunen E, Slater R, Mooy CM, Paridaens DA, Luyten GPM, de Klein A. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Clin Cancer Res. 2002;8:534–9.
Onken MD, Worley LA, Tuscan MD, Harbour JW. An accurate clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn. 2010;12:461–8.
Shields CL, Manquez ME, Ehya H, Mashayekhi A, Danzig CJ, Shields JA. Fine-needle aspiration biopsy of iris tumors in 100 consecutive cases. Ophthalmology. 2006;113:2080–6.
Shields CL, Ramasubramanian A, Gangula A, Mohan D, Shields JA. Cytogenetic testing of iris melanoma using fine needle aspiration biopsy in 17 patients. Retina. 2011;31(3):574–80.
Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 1997;19:22–8.
Sisley K, Nichols C, Parsons MA, Farr R, Rees RC, Rennie IG. Clinical applications of chromosome analysis, from fine needle aspiration biopsies, of posterior uveal melanomas. Eye. 1998a;12:203–7.
Sisley K, Brand C, Parsons MA, Maltby E, Rees RC, Rennie IG. Cytogenetics of iris melanomas: Disparity with other uveal tract melanomas. Cancer Genet Cytogenet. 1998b;101:128–33.
Van den Bosch T, van Beek JGM, Vaarwater J, Verdijk RM, Naus NC, Paridaens D, de Klein A, Kilic E. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. Invest Opthalmol Vis Sci. 2012;53(6):2668–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Biscotti, C.V. (2016). Molecular Biomarkers in Prognostication of Uveal Melanoma. In: Yang, B., Rao, J. (eds) Molecular Cytopathology. Essentials in Cytopathology, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-30741-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-30741-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30739-8
Online ISBN: 978-3-319-30741-1
eBook Packages: MedicineMedicine (R0)